☆ 4.1 Article

A Randomized, Placebo-Controlled Study of the Pharmacokinetics, Pharmacodynamics, and Tolerability of the Oral JAK2 Inhibitor Fedratinib (SAR302503)in Healthy Volunteers

JOURNAL OF CLINICAL PHARMACOLOGY (2014)

Get Full Text
Add to Collection

Journal

JOURNAL OF CLINICAL PHARMACOLOGY
Volume 54, Issue 4, Pages 415-421

Publisher

WILEY
DOI: 10.1002/jcph.218

Keywords

-

Categories

Pharmacology & Pharmacy

Funding

  1. Sanofi

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.